LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Design and development of metabolically competent cell lines for high throughput, chemical compound, toxicity testing

Photo from archive.org

HEK293 cells stably expressing OATP1B1 or OATP1B3 or HepG2 cells were plated into 6-well plates at 3 X 105 cells/well. After overnight incubation, the cells were transfected with 0.5ug –… Click to show full abstract

HEK293 cells stably expressing OATP1B1 or OATP1B3 or HepG2 cells were plated into 6-well plates at 3 X 105 cells/well. After overnight incubation, the cells were transfected with 0.5ug – 2ug Simplicon/well in the presence of 200ng/ml B18R IFN binding protein. The following day, cells were removed, counted and plated into 96-well plates at 1 X 105 cells/well in 200ul DMEM/F12 growth media containing 0.1ug/ml puromycin and 200ng/ml – 600ng/ml B18R protein. The next day, the cells were treated with substrate compounds (10uM, with the exception of phenacetin which was 40uM) for 2-3 hours in serum-free medium and assayed for metabolite production by mass spectrophotometry. Cells that were incubated for 144 hours were passaged and scaled into the same growth media supplemented with 0.1ug/ml puromycin and 200ng/ml B18R IFN binding protein. Introduction

Keywords: lines high; competent cell; cell lines; design development; metabolically competent; development metabolically

Journal Title: Drug Metabolism and Pharmacokinetics
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.